A Commercial-Stage Opportunity in the Fastest-Growing Cannabis Segment
Ryan Allway
September 25th, 2018
Exclusive, News, Top News
The cannabis industry is projected to reach more than $146 billion by 2025, according to Grand View Research, representing a 34.6 percent compound annual growth rate. While flower remains the best seller in many markets, oils and concentrates have become the fastest growing segments of the market. BDS Analytics recently found that flower’s market share fell ten percent while concentrates gained about six percent.
Halo Labs Inc. is a leading manufacturer of cannabis oils and concentrates that delivers over 100,000 grams per month and generated more than $10.3 million in revenue last year. After capturing a fifth of Oregon’s market, the company expanded into Nevada and California this year. Investors may want to take a closer look at this pre-public company given management’s proven track record and the significant growth opportunity ahead.
Sign up to receive a free IPO alert and download the company’s investor presentation.
Growing Demand for Oils & Concentrates
BDS Analytics found that cannabis flower market share fell from 54 percent to 44 percent of dispensary sales in Oregon over the past year. By comparison, concentrates rose from 21 percent to 27 percent of the market, and edibles rose from 11 percent to 16 percent of the market. Live resin and wax were the top-performing concentrates over the past year with gains of 200 percent and 300 percent, respectively.
These same trends are playing out in emerging recreational markets like California and Nevada. Prior to the legalization of recreational cannabis, California-based cannabis delivery company Eaze reported a 400 percent increase in oil cartridge purchases between 2015 and 2016 alone—totaling a quarter of the company’s total sales. Consumers are demanding stronger, healthier, and more discreet ways to consume cannabis.
It’s not just consumers that have been bullish on concentrates—businesses are starting to see the value as well. With wholesale flower prices on the decline across the U.S., more and more cultivators are turning to concentrates to generate higher yields on their grows. Concentrates have significantly higher and defensible profit margins due to the wide range of available products and unique formulations relative to flower products.
Investment Opportunities in the Space
There are hundreds of different investment opportunities in the cannabis industry, ranging from Canadian licensed producers to U.S. dispensary chains. Only a handful of these companies are generating tangible revenue and even fewer have defensible profit margins. Cannabis prices have moved lower as production ramps up across North America and the best opportunities are cultivators with a strong market share in high-margin concentrates.
Halo Labs has already captured one-fifth of Oregon’s wholesale cannabis concentrates market with over 2.5 million grams sold and $20 million in revenue since 2016. The company’s 12,000 sq. ft. facility and seven acres of outdoor canopy have made it an early market leader. In August, the company established an 8,000 sq. ft. processing facility near the Las Vegas Airport in Nevada, capable of a $45 million potential annual revenue run rate.
In October, the company plans to open its 9,400 sq. ft. licensed volatile and non-volatile processing facility in Cathedral City, California. The facility will be capable of producing 30,000 grams per day, which translates to a $90 million potential annual revenue run rate. Management also signed a letter of intent to establish a 15,000 sq. ft. manufacturing facility in Canada with a major licensed producer with a 50/50 profit split.
Halo Labs management team is well-equipped to bring these projects to life, with experience in both finance and the cannabis industry. In addition, it’s veteran board of independent directors and medical advisors helps ensure that it remains on the right track.
Looking Ahead
Halo Labs Inc. offers investors the opportunity to invest in an experienced operator within the highest margin segment of the cannabis industry—concentrates. With an experienced management team and existing track record of success, the company is well-positioned to leverage its 20 percent share of the Oregon wholesale concentrates business and become a leader in California and Nevada markets—both of which have multi-billion dollar potential.
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation:https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms. Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses. Tim remains a recognized voice within the investment community […]
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
Headquartered in Lakewood, Colo., STWC Holdings is a complete ecosystem of entities and services that support the burgeoning cannabis industry.
MichiCann Medical Inc. owns or controls 11 medical cannabis dispensaries in Michigan and is in the final stages to acquire another 11 shops, as well as three indoor cultivation facilities in the state.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
